Skip to content
Search

Latest Stories

Shakuntala Devi - Human Computer: THIS actress to play Vidya Balan’s daughter in the biopic

We all know that Vidya Balan will be seen in and as in Shakuntala Devi - Human Computer which is a biopic on mathematician and writer Shakuntala Devi. Today, as the whole world celebrates Daughter’s Day, the makers of the film decided to announce the name of the actress who will be seen playing the role of Vidya’s onscreen daughter. And well, the actress is none other than Sanya Malhotra. She will be seen portraying the role of Anupama Banerji, daughter of Shakuntala Devi.

Sanya has impressed us with her performances in Dangal, Pataakha and Badhaai Ho. It will surely be interesting to see her alongside Vidya in Shakuntala Devi - Human Computer. While talking about joining the cast, Sanya said, "I am very excited to play the iconic Shakuntala Devi’s daughter - Anupama Banerji. Everyone knows the achievements of the math genius Shakuntala Devi. I’m thrilled to bring onscreen this dynamic mother-daughter relationship and equally thrilled to work with Vidya Balan. Also, looking forward to my first association with Sony Pictures Networks Productions and Vikram Malhotra."


Talking about casting Sanya, director Anu Menon said, "When I met my namesake Anupama Banerji, Shakuntala’s daughter, I went to find the story of a maths whiz - but through spending time with Anupama, I found the story of a woman who was not just a computer but human too! And I can’t think of a better person than Sanya who can capture the love of a daughter for her indefinable mother! Sanya instinctively understood the character and her journey - and I can’t wait to start shooting with her. I think the audience will fall in love with both Sanya's and Vidya’s characters."

By the end of this month, Sanya will join the team of the film in the London schedule.

More For You

pharmacy

The UK spends just 9 per cent of healthcare budgets on medicines while patients face growing access gaps.

iStock

UK calls for new pharmaceutical investment to strengthen life sciences

Highlights

  • UK life sciences sector contributed £17.6bn GVA in 2021 and supports 126,000 high-skilled jobs.
  • Inward life sciences FDI fell by 58 per cent from £1,897m in 2021 to £795m in 2023.
  • Experts warn NHS underinvestment and NICE pricing rules are deterring innovation and patient access.

Investment gap

Britain is seeking to attract new pharmaceutical investment as part of its plan to strengthen the life sciences sector, Chancellor Rachel Reeves said during meetings in Washington this week. “We do need to make sure that we are an attractive place for pharmaceuticals, and that includes on pricing, but in return for that, we want to see more investment flow to Britain,” Reeves told reporters.

Recent ABPI report, ‘Creating the conditions for investment and growth’, The UK’s pharmaceutical industry is integral to both the country’s health and growth missions, contributing £17.6 billion in direct gross value added (GVA) annually and supporting 126,000 high-skilled jobs across the nation. It also invests more in research and development (R&D) than any other sector. Yet inward life sciences foreign direct investment (FDI) fell by 58per cent, from £1,897 million in 2021 to £795 million in 2023, while pharmaceutical R&D investment in the UK lagged behind global growth trends, costing an estimated £1.3 billion in lost investment in 2023 alone.

Keep ReadingShow less